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ABSTRACT  Inorganic Se forms such as selenate or selenite (the two more 
abundant forms in nature) can be toxic in Saccharomyces cerevisiae cells, 
which constitute an adequate model to study such toxicity at the molecular 
level and the functions participating in protection against Se compounds. 
Those Se forms enter the yeast cell through other oxyanion transporters. 
Once inside the cell, inorganic Se forms may be converted into selenide 
through a reductive pathway that in physiological conditions involves reduced 
glutathione with its consequent oxidation into diglutathione and alteration of 
the cellular redox buffering capacity. Selenide can subsequently be converted 
by molecular oxygen into elemental Se, with production of superoxide anions 
and other reactive oxygen species. Overall, these events result in DNA dam-
age and dose-dependent reversible or irreversible protein oxidation, although 
additional oxidation of other cellular macromolecules cannot be discarded. 
Stress-adaptation pathways are essential for efficient Se detoxification, while 
activation of DNA damage checkpoint and repair pathways protects against 
Se-mediated genotoxicity. We propose that yeast may be used to improve our 
knowledge on the impact of Se on metal homeostasis, the identification of Se-
targets at the DNA and protein levels, and to gain more insights into the 
mechanism of Se-mediated apoptosis. 
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INTRODUCTION 
Selenium (Se) is an element that shares characteristics of 
both metals and nonmetals, being therefore considered as 
a metaloid. Similarly to sulfur, Se has different oxidation 
states ranging from +VI to –II. In the external environments 
found on earth it is present in low amounts, generally as 
selenate Se(+VI) or selenite Se(+IV), although these 
amounts vary considerably depending on the geographical 
areas [1]. Se is an essential nutritional supplement in the 
human diet, and intake doses between 30 and 55 µg per 
day are recommended, while doses lower than 10 µg per 
day can be detrimental for human health [2]. Thus, Se defi-
ciency has been associated with increased risk of mortality, 
poor immune function and cognitive decline. This nutri-
tional requirement is explained by the fact that Se (in the 
form of selenocysteine) is a component of about 25 human 
selenoproteins, among them several glutathione peroxi-
dases and thioredoxin reductases [3]. These two enzyme 
activities participate in the defense against oxidants, with a 
selenocysteine residue as part of the enzyme active site [4]. 
In addition to their known role in combating various 
forms of degenerative diseases, the impact of orga-
noselenium compounds in cancer chemoprevention has 
been studied, and thus, doses up to 200-300 µg per day are 
proposed to protect against diverse types of cancer (pros-
tate, colorectal and lung) on the basis of the Se antioxidant 
role [5-9]. However, epidemiological analyses have associ-
ated high Se levels in the serum with cardiovascular dis-
ease, amyotrophic lateral sclerosis and diabetes as well as 
with carcinogenesis [10-14]. Taken together, the narrow 
range between beneficial and toxic Se concentrations pos-
es caution on the use of Se-enriched supplements in ani-
mal and human nutrition, and makes it also difficult to 
study Se effects in human (or other animal) cell models. 
While selenoproteins are found in bacteria, archaea, some 
algae and protozoa, vertebrates and invertebrates, they 
have not been reported in fungi and plants [15, 16]. Be-
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cause Saccharomyces cerevisiae has no metabolic need for 
Se, it is an adequate organism to study the toxic effects of 
Se forms on cell functions [14]. In recent years, diverse 
studies (some of them including –omic approaches) have 
investigated the toxicity of inorganic Se forms on yeast 
cells, at the molecular and/or physiological levels. Here, we 
provide an overview on the current knowledge on Se up-
take, the impact of toxic Se on genome stability and other 
functions, and the activation of intracellular signaling 
events leading to Se detoxification and tolerance in yeast 
cells. 
 
Se COMPOUNDS IN NATURE 
In the environment, Se is found in four oxidation states, 
elemental selenium Se(0) and soluble selenate Se(+VI), 
selenite Se(+IV), and selenide Se(-II) (see Fig. 1). Se(-II) is 
found as volatile, methylated species or as organoselenium 
typically in the form of proteins containing the amino acids 
selenocysteine and selenomethionine [17]. Anaerobic mi-
croorganisms such as Thauera selenatis can respire toxic 
oxyanions of Se, namely selenate and selenite [18], and 
reduce them to insoluble Se(0) as well as hydrogen sele-
nide [19]. These microorganisms either use selenate or 
selenite as their respiratory electron acceptor for the oxi-
dation of organic carbon substrates like lactate or acetate 
to carbon dioxide. Thereby, these toxicants can be effec-
tively removed from solution via a microorganism-
mediated precipitation to non-toxic Se(0) [20]. Thus, the 
common link is that Se specification in nature is strongly 
dependent on microbial activity [21, 22]. The formation of 
Se(0) nanoparticles (20–300 nm in diameter) by selenium-
respiring bacteria and yeast is a phenomenon that de-
serves special mention [19, 23]. They occur outside the cell 
envelope, eventually slough off the cell surface and get 
released into the medium. When harvested and cleansed 
of their cellular parents, they were found to have curious 
electro-optical properties, making them candidates for 
further studies with “nanotechnological” applications [24]. 
Inorganic Se compounds can also be metabolized inside 
the cell through a reductive pathway from selenate to 
selenide (Fig. 1). This process involves reduced glutathione 
(GSH) with the consequent formation of oxidized glutathi-
one (GSSG) and reactive oxygen species (ROS) [25-27]. 
Selenide is also the intermediate for the formation of sele-
nocysteine, from which selenomethionine can then be 
formed in organisms with a functional transsulfuration 
pathway. Several metabolomics studies [28-30] have 
shown that a plethora of additional organoselenium com-
pounds accumulate in yeast cells supplemented with sele-
nate, selenite or selenomethionine, in addition to demon-
strating that selenocysteine can also be formed from sele-
nomethionine. 
 
UPTAKE OF INORGANIC Se FORMS 
Specific transporters for uptake of inorganic Se compounds 
still need to be characterized in eukaryotic cells. In S. cere-
visiae, selenate probably enters through the high affinity 
sulfate permeases Sul1 and Sul2. Thus, a double mutant 
lacking both transporters is hyperresistant to selenate as 
well as to chromate [31], suggesting that both oxyanions 
adventitiously employ the sulfate transporters to enter 
into the yeast cells. Consistent with this observation, later 
experiments demonstrated that chromate and sulfate 
compete with each other to enter into the cells [32], alt-
hough similar experiments have not been done with sele-
nate. Also, heterologous expression of a plant sulfate 
transporter, SHST1, in S. cerevisiae sul1 mutant cells allows 
increased uptake of molybdate, while increasing molyb-
 
 
FIGURE 1: Scheme for the metabolic reduction of inorganic selenium forms, and their conversion into organic forms. Reductive reactions 
are indicated with red arrows. Arrow 1 corresponds to the reactions involving ATP sulfurylase and other enzymes that take part in the initial 
steps of the sulfate assimilation pathway. Reactions 2 to 5 are non-enzymatic and result in the net conversion of reduced glutathione (GSH) 
into oxidized glutathione (GSSG). Reaction 6 is also non-enzymatic and results in the formation of diverse reactive oxygen species. Adapted 
from [25], [26], [27] and [36]. 
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date concentration in the medium interferes with sulfate 
entry [33], suggesting that sulfate and molybdate share the 
same transport system. Therefore, the Sul1/Sul2 transport 
system seems to be used by diverse oxyanions (+VI) for 
entry into S. cerevisiae.  
Initial work on the kinetics of selenite uptake indicated 
the existence of both a high affinity and a low affinity 
transport system operating at different selenite concentra-
tions [34]. In parallel, another study pointed to the interac-
tion between selenite and ortophosphate assimilation [35]. 
On the other hand, reducing molecules present in the 
growth medium such as glutathione or other thiols would 
reduce selenite to hydrogen selenide, which would then be 
internalized into the cells to cause toxicity [36]. However, 
there is no evidence of the existence of selenide transport-
ers in S. cerevisiae or other eukaryotic organisms.  
A detailed study by Lazard et al. [37] confirmed that 
selenite employs phosphate transporters to enter into 
yeast cells. Two different transport systems mediate or-
tophosphate uptake in S. cerevisiae [38, 39]. The high affin-
ity phosphate transport system is composed of the Pho84 
and Pho89 transporters and functions at both low and high 
phosphate concentrations. Expression of the PHO84 and 
PHO89 genes is upregulated at low phosphate concentra-
tion depending on the PHO signal transduction pathway, 
with the Pho4 transcription factor as effector of the path-
way [40]. Pho84 transporter operates preferentially at neu-
tral and acidic pH, while Pho89 is functional at alkaline pH 
[41]. The low affinity transport system operates at high 
phosphate concentrations, is composed by Pho87, Pho90 
and Pho91, and is post-transcriptionally downregulated at 
low phosphate conditions by Spl2, a member of the PHO 
regulon [38, 39]. Depending on phosphate levels in the 
medium, selenite enters the yeast cell through Pho84 or 
Pho87/Pho90/Pho91 [37]. At very low phosphate levels (up 
to 0.1 mM) selenite enters efficiently through Pho84 and is 
highly toxic. Given that Pho84 displays a much higher affin-
ity for phosphate than for selenite, while the phosphate 
low affinity system is considerably more unspecific, phos-
phate favorably competes with selenite at moderately 
higher phosphate levels (up to 0.4 mM) and selenite be-
comes less toxic. At still higher phosphate levels selenite 
enters through the less discriminatory low affinity system 
and becomes highly toxic again [37]. Interestingly, arsenate 
also can adventitiously enter S. cerevisiae cells through the 
Pho84 and phosphate low affinity transporters [42, 43], 
indicating that phosphate transporters contribute to the 
toxic uptake of a wide range of compounds [44]. 
Glucose was the only carbon/energy source used in the 
studies described above but apparently, the Jen1 trans-
porter acts as an alternative selenite and arsenite trans-
porter in the presence of other carbon sources [45]. The 
JEN1 gene codes for a plasma membrane high affinity 
transporter of monocarboxylic acids such as lactate, py-
ruvate or acetate [46], and monocarboxylic acids can com-
pete with selenite for entrance into the yeast cell [45]. 
Glucose represses expression of JEN1 [47], and induces 
endocytosis and ubiquitin-mediated degradation of the 
Jen1 protein [48]. Thus, the Jen1 transporter would not 
operate in glucose medium where the above mentioned 
phosphate transporters would be the mediators of selenite 
uptake. The efficient adventitious transport of selenite by 
Jen1 in conditions where a carbon source alternative to 
glucose is employed by the yeast cells would explain why 
selenite toxicity is increased in respiratory growth condi-
tions [49, 50]. 
In summary, selenite opportunistically employs mecha-
nisms involved in transport and metabolic conversion of 
essential nutrients in order to enter into yeast cells. Inter-
estingly, overexpression of the SSU1 gene (encoding for a 
plasma membrane sulfite pump which acts as a sulfite de-
toxifier in yeast cells [51]) also confers selenite tolerance 
[52], indicating the existence of common export mecha-
nisms for sulfite and selenite. 
  
MECHANISMS OF Se TOXICITY IN YEAST CELLS 
Selenite and selenide cause the death of S. cerevisiae cells 
in a dose-dependent manner [52-54]. In contrast, equiva-
lent concentrations of organic forms of Se (selenocysteine 
or selenomethionine) do not provoke lethality [53], alt-
hough some inhibitory effects on cell growth may occur, at 
least in the case of selenomethionine [29, 55]. Selenate is 
also toxic for yeast cells, although considerably less than 
selenite when equivalent concentrations are compared for 
effects on cell viability, ROS production or DNA damage 
[56]. This could be due to less efficient uptake of selenate 
or only partial metabolic conversion to selenite and sele-
nide. Cells lacking the Met3 ATP sulfurylase activity are 
resistant to high selenate concentrations [57], yet the 
question if its resistance is due to impaired selenate to 
selenite conversion or a consequence of a repres-
sion/inhibition of sulfate transporters is still under debate 
[58]. It would be interesting to see if overexpression of 
MET3 or genes coding for related enzymatic activities may 
be a tool to further dissect the contribution of selenate 
uptake or its intracellular metabolic conversion to selenate 
toxicity. 
 
Genotoxic effects 
Toxicity of the inorganic Se forms results from different 
physiological effects that are interrelated. Selenite-treated 
yeast cells are prone to DNA double strand break (DSB) 
formation and show increased mutation rates [52, 53]. 
DSBs may result from the chemical alteration of DNA bases 
by selenite-mediated ROS that challenge replication fork 
integrity and genome stability in proliferating cells. How-
ever, although at lower levels, selenite also provokes DSB 
formation in stationary phase yeast cells [53], pointing to 
DNA replication-independent damage mediated by selenite 
(or its metabolic derivative selenide, see below). Selenite 
compounds have been shown to induce apoptotic death of 
tumor cells involving topoisomerase II (Top II) [59, 60]. Top 
II action involves the cleavage of both DNA strands [61] 
and selenite stabilizes reversible TopII cleavage complexes 
in vitro, suggesting that the stimulation of Top II action 
may be a main source of selenite-mediated DNA breaks. 
Selenide also breaks DNA phosphodiester bonds in vitro 
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under aerobic conditions, due to the action of ROS differ-
ent from O2•-, and similar effects may be caused by sele-
nite provided that GSH is present in the reaction mixture 
[55].  
In yeast cells DNA DSBs are mainly repaired by the ho-
mologous recombination (HR) pathway, taking advantage 
of sister chromatids as DNA repair templates [62]. In ac-
cordance, a genome-wide analysis of selenite sensitive 
mutants in haploid S. cerevisiae cells has revealed that HR 
mutants are selenite-hypersensitive [63], confirming previ-
ous results on the importance of HR in protecting yeast 
cells against selenite-induced DNA damage [52, 64]. In ad-
dition to HR, Rad5/Rad6-mediated post-replicative repair 
(PRR) is required to protect cells from selenite-mediated 
DNA damage [61, 65]. Although HR and PRR seem to have 
a synergistic effect in repairing selenite-mediated DNA 
damage, exposure to selenite does not stimulate the ex-
pression of DNA repair genes [63, 66]. Notably, despite the 
role of non-homologous end-joining (NHEJ) in the repair of 
DNA DSBs [67], mutants impeded in NHEJ were dispensa-
ble for tolerance to selenite-mediated DNA damage [68]. 
NHEJ is the markedly preferred option for the repair of 
DNA lesions formed outside of the S/G2 phase of the cell 
cycle [69], suggesting a predominant impact of selenite on 
the genome stability of replicating and/or dividing cells. 
A recent study by Peyroche et al. revealed that selenide 
treatment causes oxygen-dependent DNA phosphodiester-
bond breaks in vitro, and chromosome fragmentation in 
vivo [54]. The same study included a genome-wide screen 
to identify mutants that confer selenide hypersensitivity. 
Apparently, the repair of selenide-mediated lesions de-
pends on HR, suggesting an overlap in the kind of DNA 
lesions generated by selenide and selenite. Based on these 
observations, it is conceivable that cells reduce selenite to 
selenide in the presence of oxygen thereby promoting ROS 
and DNA damage formation [54].  
Despite the advance in our knowledge on the mecha-
nisms that contribute to the formation and repair of Se-
mediated DNA damage, little is known on the possible im-
pact of Se on proteins involved in DNA metabolism. It will 
be interesting to see if Se compounds interfere with disul-
fide bridge formation and protein folding, or the function 
of metalloproteins such as DNA polymerases [70]. 
 
Alteration of mitochondrial functions 
Mitochondria play an important role in cellular energy 
supply and apoptosis in yeast and higher eukaryotes [71, 
72]. Mitochondrial functions are highly conserved from 
yeast to human, and yeast-based assays have been em-
ployed to identify drugs active against human mitochon-
drial disorders [73]. The intermembrane space of mito-
chondria contains several pro-apoptotic proteins, including 
cytochrome c, procaspases 2, 3, and 9, and apoptosis-
inducing factor, all of which are released into the cytosol as 
a result either of disruption of the outer mitochondrial 
membrane or of the opening of specific pores [74]. The 
opening of the mitochondrial permeability transition (MPT) 
pore induced by apoptotic stimuli is thus thought to result 
in the swelling of the mitochondrial matrix and consequent 
rupture of the outer membrane and release of pro-
apoptotic proteins. MPT pore opening is regulated by Ca
2+
, 
thiol oxidants, ROS, and members of the Bcl-2 family of 
proteins [75-78]. S. cerevisiae has been very useful to dis-
sect the underlying mechanisms that contribute to apopto-
sis but little is known on the impact of Se on yeast mito-
chondrial function. In human cells, apoptotic events that 
are mediated by selenite, selenocystine, and selenodioxide 
are related to oxidation of protein thiol groups and ROS 
generation [79]. In addition, selenite has been found to 
promote transitions in mitochondrial permeability, and 
cytochrome c release in isolated mitochondria [80]. How-
ever, enhanced Se uptake has also been shown to improve 
mitochondrial function, most likely because 3 out of 25 
mammalian selenoproteins (TR2, GPX4 and SelO) were 
shown to reside in mitochondria. These proteins function 
in the regulation of mitochondrial redox homeostasis and 
antioxidant activity [81-83]. Despite the fact that S. cere-
visae is lacking mitochondrial selenoproteins, toxic Se may 
as well induce apoptotic events in yeast [50]. Se and mito-
chondrial DNA are not essential for S. cerevisae growth 
[84], thus it was possible to identify yeast genes involved in 
mitochondrial function that affect intracellular Se levels 
[85]. It remains to be explored as to whether mutations in 
human genes related to mitochondrial function will affect 
mitochondrial Se levels, or be relevant in disease formation.   
 
Effects on the cellular redox state 
Once inside the cell selenite would employ the sulfate as-
similation pathway for its conversion into the more toxic 
form selenide [86]. In fact, a genome-wide screen for S. 
cerevisiae mutants displaying selenite tolerance revealed 
that the mutants in genes involved in the conversion of 
sulfate into sulfur were tolerant to selenite and also to 
tellurite, supporting an opportunistic common assimilation 
pathway for both toxic oxyanions [86]. The sulfur (or sele-
nite) assimilation pathway involves a sequence of redox 
reactions [87]. In the case of selenite, the above study also 
demonstrated that intracellular selenite reduction is linked 
to GSH metabolism, as a gsh2Δ mutant defective in GSH 
biosynthesis is also unable to accumulate elemental sele-
nium [86], although this does not result in increased toler-
ance to selenite [63, 86]. The involvement of GSH in sele-
nite reduction has also been initially shown in bacteria [88]. 
In yeast, the Glr1 glutathione reductase is the enzyme in-
volved in maintaining most of the glutathione intracellular 
pool in a reduced state. This tripeptide molecule is the 
main intracellular redox buffer, as it is needed for the activ-
ity of redoxins, peroxidases and metal-detoxifying enzymes 
among others, besides forming reversible disulfide bonds 
with protein thiols to protect them against irreversible 
oxidation [89]. Selenite causes a decrease of the GSH/GSSG 
ratio in the cell, in addition to reduction of total glutathi-
one [28, 90, 91]. Accordingly, overexpression of GLR1 par-
tially rescues the inhibitory effect of selenite on yeast cell 
growth [52], while a glr1∆ mutant is hypersensitive to sel-
enite, as well as a gsh1∆ mutant involved in the first step of 
GSH biosynthesis [63]. The glr1∆ and gsh1∆ mutants have 
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also been described as hypersensitive to sodium selenide 
[54], again pointing to common toxicity effects between 
both inorganic forms of Se. A drop in intracellular GSH lev-
els should constrain the activity of GSH-dependent ROS-
detoxifying enzymes, and thus lead to ROS accumulation 
and macromolecular damage. Accumulation of intracellular 
hydrogen peroxide upon selenite treatment has been re-
ported [49], and in addition to the above described geno-
toxic effects, selenite also provokes irreversible ROS-
mediated carbonylation of protein side chains [50]. A 
metabolomics study has shown that the drop in intracellu-
lar GSH levels is much lower in selenate-treated cells than 
in selenite-treated ones [28], which could contribute to the 
lower toxicity of selenate. 
The observed drop in the intracellular glutathione pool 
upon selenite treatment cannot be simply explained by the 
reduction of the cytosolic GSH pool due to reduction of 
selenite to selenide and ROS. Detoxification of heavy at-
oms such as cadmium, arsenic or mercury in yeast involves 
the participation of the vacuolar membrane located ABC 
transporter Ycf1 [44, 92]. Ycf1 internalizes GSH-heavy met-
al conjugates into the vacuolar lumen, therefore conferring 
heavy metal tolerance and thus, the ycf1∆ mutant is hyper-
sensitive to heavy metals. On the contrary, the ycf1∆ mu-
tant is resistant to selenite, while overexpression of Ycf1 
exacerbates selenite toxicity [90], indicating a more com-
plex function of the Ycf1 pump in selenite tolerance. Ycf1 is 
able to transport GSSG and selenodiglutathione (GSSeSG) 
[90]. This finding led to the proposal of a vicious cycle of 
selenite-mediated cytosolic GSH depletion, based on a 
continuous Ycf1-dependent vacuolar internalization of 
GSSG and GSSeSG. In the vacuole, GSSeSG converts to 
GSSG and selenide. In this case, selenide would again dif-
fuse to the cytosol, while GSSG would be retained in the 
vacuole causing cytosolic glutathione depletion. Such sce-
nario explains how vacuolar internalization of Se com-
pounds alters the intracellular redox state. However, the 
functional integrity of vacuoles is also essential to cope 
with Se toxicity [63], as it will be discussed below.  
Transcriptome analysis of selenide- and selenite-
treated S. cerevisiae cells revealed the induction of genes 
participating in the oxidative stress response [54, 63, 65] 
that are expressed under control of the AP-1 family like 
Yap1 transcription factor [93]. Genes that were upregulat-
ed by selenite included thioredoxin reductase (TTR1) and 
glutathione reductase (GLR1), both coding for activities 
required for functional (NADPH-dependent) thioredoxin 
and (glutathione-dependent) glutaredoxin systems, respec-
tively. These two systems control the redox state of pro-
tein thiol groups through their thiol oxidoreductase activity 
and consequently, are important for repairing oxidation of 
these thiol groups and for protein redox modulation [94, 
95]. Selenite also induces expression of peroxidases, the 
cytosolic catalase and Cu/Zn-dependent superoxide dis-
mutase SOD1 [66]. Because these enzymes are involved in 
ROS detoxification, these observations reinforce the idea 
that the selenite/selenide treatment of the yeast cells 
causes alterations in the intracellular redox state. 
The alteration of the GSH/GSSG ratio by selenite may 
result in general oxidation of protein thiol groups. This 
would explain the reported protection of dithiol glu-
taredoxins Grx1 and Grx2 against selenite toxicity [49, 50]. 
In fact, Grx1 and Grx2 have a defense function against oxi-
dative stress in S. cerevisiae [96], although the biochemical 
bases of such differential protection are not characterized. 
A double grx1∆ grx2∆ mutant is hypersensitive to selenite 
[49, 50], while the respective single mutants are not, which 
would support overlapping roles for both glutaredoxins 
during selenite stress [50]. Another study, however, has 
attributed a more important role to Grx1 in such protec-
tion, relating it to the predominant participation of super-
oxide in selenite-generated oxidative stress [63]. The grx1∆ 
mutant has also been described as selenide-hypersensitive 
[54]. All these studies commonly point to the importance 
of yeast dithiol glutaredoxins in protection against selenite 
and selenide, probably through regulation of protein thiol 
oxidation. The reported peroxidase activity of those glu-
taredoxins [97] might as well contribute to such protection. 
 
SIGNALING PATHWAYS FOR Se STRESS 
Diverse stress response pathways sense the lesions caused 
by Se compounds in yeast cells and induce protective re-
sponses. Given the diversity of the toxic effects triggered 
by selenite or selenide, it is not surprising that several re-
sponse transducers and effectors may be acting in parallel. 
Disruption of the pathways or effector loss of function re-
sults in hypersensitivity to Se molecules. 
 
The DNA damage checkpoint pathway 
Upon DNA damage, cell cycle arrest by G1/S, S and G2/M 
cell cycle checkpoints is essential to avoid unscheduled 
repair of DNA lesions [98]. In yeast, Rad9 is a central medi-
ator of checkpoint activation throughout the cell cycle [99]. 
DNA lesions induce cyclin-dependent kinase or Mec1 me-
diated Rad9 phosphorylation and subsequent activation of 
signal transducers such as Rad53, which itself phosphory-
lates diverse downstream effectors [100-102]. In addition, 
Mec1 accumulation at stalled replication forks activates 
Mrc1, a replication fork component needed to upregulate 
Rad53 phosphorylation [103]. Therefore, several phos-
phorylation events could act in parallel to promote the 
activation of DNA damage response mediator proteins. 
Mutants in RAD9 and other genes of the pathway are hy-
persensitive to DNA damage mediated by UV light, DNA 
alkylating agents or selenite [54, 99]. Because selenite 
treatment causes cells to arrest at G2/M [52], Rad9-
dependent activation of the DNA damage checkpoint 
pathway seems to be important for the selenite-dependent 
cell cycle arrest. Furthermore, checkpoint mutants with a 
specific function in different stages of cell cycle are hyper-
sensitive to selenite [52, 65], suggesting that selenite caus-
es DNA damage throughout the cell cycle. In contrast, mu-
tants in RAD9 and other genes coding for central compo-
nents of the DNA damage response are not hypersensitive 
to selenomethionine [65]. It is therefore unlikely that this 
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organic form of Se contributes to Se-mediated genotoxicity 
[56]. 
 
The Snf1 kinase pathway in response to oxidative stress 
Yeast Snf1 was identified as having a general role in the 
oxidative stress response and selenite tolerance [91]. Snf1 
is a yeast member of the AMP-activated protein kinase 
(AMPK) family constituted by protein complexes that par-
ticipate in metabolic stress responses responsible for the 
maintenance of cellular ATP levels in eukaryotes. Thus, 
Snf1 plays a key role in the adaptation of yeast cells to glu-
cose limitation and the usage of alternative carbon sources 
[104]. To carry out this function, upstream acting protein 
kinases (Sak1, Elm1 or Tos1) sense the carbon source stress 
conditions, phosphorylate Snf1 (with Sak1 being the major 
player in the response to glucose scarcity) and promote its 
internalization to the nucleus to activate several transcrip-
tion regulator targets acting as effectors of this kinase. 
More recently, it has been demonstrated that Snf1 does 
not only regulate nuclear targets, but also can modulate 
the function of cytosolic proteins, such as the arrestin-
related protein Rod1, which coordinates endocytosis of 
alternative carbon source transporters in response to glu-
cose presence in the medium [105]. The work of Pérez-
Sampietro et al. [91] demonstrated that Elm1-dependent 
activation of Snf1 is required for protection against oxi-
dants (among them selenite) causing alteration of glutathi-
one redox homeostasis towards a more oxidized state. This 
protection does not require the nuclear targets of Snf1 
operating during the glucose depletion response, overall 
defining a previously uncharacterized response against 
oxidative stress conditions with the participation of the 
Snf1 kinase. Similarly, Snf1 activity is required for cadmium 
tolerance independent of its nuclear targets [92]. Interest-
ingly, in human cell lines, hydrogen peroxide activates 
AMPK as part of a protective signaling mechanism mediat-
ed by mTORC1 [106]. In another study on human colon 
cancer cells, selenate provoked a late activation of AMPK 
through ROS formation, and this AMPK activation was es-
sential to inhibit cell proliferation by downregulating the 
COX2-mediated pathway [107]. An additional work with 
human cell lines also demonstrated activation of AMPK by 
redox changes in the α and β subunits of the AMPK com-
plex induced by hydrogen peroxide [108]. In summary, 
there is experimental evidence from a diversity of cell 
types supporting the involvement of AMPK in the response 
to stress by redox-altering agents, including Se compounds. 
 
The Rim101-mediated pathway and vacuolar functions 
Rim101 is a member of the fungal PacC family of C2H2 zinc 
finger transcriptional regulators that was initially charac-
terized as modulator of the response of yeast cells to alka-
line pH. Later studies showed its implication in processes 
such as sporulation and invasive growth, protection against 
Na
+
 and Li
+
 toxicity, cell wall assembly, protection against 
weak organic acids and regulation of calcium homeostasis 
[109-112]. A recent study [113] has extended the range of 
cell processes regulated by Rim101 to vacuolar functions. 
In this process Rim101 would act cooperatively with the 
ESCRT complex, a protein complex that was originally iden-
tified as being important for the sorting of ubiquitinated 
endosomal membrane proteins into the multivesicular 
body (MVB) [114, 115]. Further studies demonstrated addi-
tional roles of the ESCRT machinery in other cellular pro-
cesses [114, 115], including the Rim101 signaling pathway 
in yeast [110, 111]. In the absence of Rim101, expression 
of several VMA genes implicated in the synthesis of subu-
nits of the vacuolar H
+
-ATPase (V-ATPase) complex be-
comes downregulated, providing a rationale for the sele-
nite hypersensitivity of the rim101∆ mutant [113]. On the 
contrary, constitutive activation of Rim101 prevents inhibi-
tion of vacuolar acidification caused by selenite. V-ATPase 
activity is required to maintain the acidity of the vacuolar 
lumen necessary for importing a number of different mole-
cules into the vacuole, including the toxic ones [116]. 
These observations, together with the fact that mutants in 
the genes encoding the different V-ATPase subunits are 
hypersensitive to selenite [63], point to a scenario in which 
Rim101 modulates the vacuolar acidity necessary for sele-
nite detoxification through its transcriptional activity. In 
this scenario, the ESCRT machinery would participate in 
maintenance of vacuolar acidity through both Rim101-
dependent and -independent pathways. Consistently with 
this, ESCRT mutants are also hypersensitive to selenite 
[113]. 
 
CONCLUSIONS AND PERSPECTIVES 
The mechanisms by which Se compounds enter into S. 
cerevisiae cells and interfere with cellular processes are 
summarized in Fig. 2, which also depicts the activation of 
pathways required for Se tolerance and detoxification. 
Entrance of selenate and selenite (the two more abundant 
free forms of Se in nature) occurs through oxyanions 
transporters, and once in the cell they are transformed into 
selenide through a reductive pathway that may involve 
GSH. In the presence of oxygen, selenide can promote the 
formation of superoxide and other ROS species, which may 
damage DNA, proteins and probably also other cellular 
macromolecules. Thus, changes in the redox buffering of 
the cell and ROS overproduction, which themselves are 
two interrelated processes, would be an origin of Se toxici-
ty.  
However, many questions remain. Selenite has been 
shown to activate expression of genes under transcription-
al control of the Aft1 regulon [66]. Genes affected encode 
for proteins required for the high-affinity uptake of iron 
and redistribution of internal iron stores under iron scarcity 
[117, 118]. In addition, cells lacking Aft1 are moderately 
hypersensitive to selenite, this phenotype being rescued by 
iron supplementation to the growth medium [113]. These 
observations may indicate that selenite (or selenide) would 
interfere with iron bioavailability, the Aft1-mediated re-
sponse being required in such conditions. A study has ad-
dressed the ability of selenide to form insoluble complexes 
in vitro with different metal anions, confirming in fact its 
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interaction with ferrous iron and that the selenide- iron 
complexes become biologically inactive [119]. The possibil 
ity that in vivo interference can be extended to other ani-
ons is open. In addition, yeast as model organism offers the 
possibility to address the identification of hot spots of Se-
mediated DNA damage, or to extend our knowledge on 
factors involved in signaling and repair of Se-mediated 
damage. It will be interesting to determine which proteins 
are prone to selenite or selenide-dependent modifications, 
including irreversible (i.e. carbonylation) or reversible 
(phosphorylation, ubiquitination, sumolyation) protein 
modifications. Finally, yeast may serve as an excellent tool 
for the characterization of events related to Se-mediated 
aging and apoptosis. Such studies are important for a bet-
ter understanding of the molecular mechanism underlying 
Se-mediated pathologies in multicellular organisms, includ-
ing humans. 
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